Page 2 - Viatris Company News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Theravance Biopharma, Inc Announces Final Results of Tender Offer

/PRNewswire/ Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced the final results of its Dutch auction.

New yorkUnited statesTheravance biopharmaAndrew hindmanComputershare trust companyTheravance biopharma incSecurities exchangeViatris companyCompany quarterly report on formEvercore groupNew york cityPrivate securities litigation reform actSecurities exchange actQuarterly report

Theravance Biopharma, Inc Announces Final Results of Tender Offer

Theravance Biopharma, Inc Announces Final Results of Tender Offer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesTheravance biopharmaComputershare trust companyTheravance biopharma incSecurities exchangeViatris companyCompany quarterly report on formEvercore groupNew york cityPrivate securities litigation reform actSecurities exchange actQuarterly reportAndrew hindmanchief financial officer

Theravance Biopharma, Inc Announces Preliminary Results of Tender Offer

/PRNewswire/ Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced the preliminary results of its Dutch.

New yorkUnited statesTheravance biopharmaAndrew hindmanComputershare trust companyTheravance biopharma incSecurities exchangePrnewswire theravance biopharma incViatris companyCompany quarterly report on formEvercore groupNew york cityPrivate securities litigation reform actSecurities exchange actQuarterly reportHealth care amp hospitals

Theravance Biopharma, Inc Reports Third Quarter 2022 Financial Results, Provides Business Update and Extends Tender Offer

Reported another record quarter of YUPELRI® (revefenacin) net sales and profitability: $18.7 million Q3 2022 sales up 35% from Q3 2021 (TBPH implied 35%.

New yorkUnited statesRicke winninghamTheravance biopharmaAndrew hindmanComputershare trust companyCompany offer to purchaseMillion capital return programInternational symposiumDrug administrationTheravance biopharma incCompany annual report on formCompany formDevelopment rd expensesTheravance respiratory companySecurities exchange

Ampreloxetine Data in Neurogenic Orthostatic Hypotension to be Presented at the 33rd International Symposium on the Autonomic Nervous System

/PRNewswire/ Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today will present new ampreloxetine data in neurogenic.

San diegoUnited statesTheravance biopharmaAndrew hindmanStroy freemanCompany phaseAmerican autonomic societyClinical program demonstrates ampreloxetineUc san diego health movement disorder centerBeth israel deaconess medical centerInternational symposiumTheravance biopharma incCompany formSecurities exchangePrnewswire theravance biopharma incViatris company